Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Lakefront Biotherapeutics NV (GXE) vs. Competitors

6 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:GXELakefront Biotherapeutics NVEUR 31.52EUR 2.06B4.2218.41%Moderate SellUnlock the DE:GXE analyst price target with TipRanks PremiumDE:GXEUnlock the DE:GXE top-analyst price target with TipRanks Premium
NL:PHARMPharming GroupEUR 1.12EUR 809.70M35.75-19.47%―Unlock the NL:PHARM analyst price target with TipRanks PremiumDE:GXE vs NL:PHARMUnlock the NL:PHARM top-analyst price target with TipRanks Premium
NL:VVYVivoryon Therapeutics AGEUR 0.71EUR 21.62M-3.17-56.65%―Unlock the NL:VVY analyst price target with TipRanks PremiumDE:GXE vs NL:VVYUnlock the NL:VVY top-analyst price target with TipRanks Premium

Performance Comparison

-75%-50%-25%0%25%50%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:GXELakefront Biotherapeutics NV31.525.3620.49%
NL:PHARMPharming Group1.12-0.26-19.12%
NL:VVYVivoryon Therapeutics AG0.71-0.92-56.44%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts